How could treatment practice change with cancer immunotherapy combinations in patients with HCC?

Friday, September 11, 2020 12:00 PM to 1:00 PM · 1 hr. (Africa/Abidjan)
WATCH LIVE channel 1
Industry symposium

Information

Roche are pleased to present this industry-sponsored symposium. An esteemed panel will provide an overview of the evolving treatment landscape for HCC, review the most recent data for cancer immunotherapy combinations in patients with unresectable HCC and, crucially, provide expert insights and guidance on how their safety profiles can be navigated.

DISCLAIMER

This symposium is intended only for physicians practicing outside the USA.